PHS-Tomskhimpharm JSC

Company Profile

Address: 211, Prospekt Lenina, Tomsk, Tomsk Region, 634009
Telephone/fax: (382-2) 40-28-56
Staff: 396 employees
Product range: 25 items
Number of SKU: 59 items
2017 Output: 25 mln packs
Awards and Achievements: The largest manufacturer of finished pharmaceutical products in Western Siberia. GMP-certified since 2010.
The Company celebrated its 80th anniversary in 2016.

Resources and Capabilities

Capacity: 108 mln packs 
Total area: 30,144 thd. sqm.
Manufacturing area: 11.7 thd. sqm.
Number of production lines: 7
Manufacturing dosage forms: Liquid dosage forms
  • Tincture
  • Solution for outward application and for manufacture of dosage forms;
  • Liquid extract for oral use; syrupy extract;
  • Nasal spray
Solid dosage forms
  • Tablets; orodispersible tablets; film-coated tablets; extended release tablets
Soft dosage forms
  • Gel for outward application
  • Creme for outward application
Pharmaceutical substances manufactured using the methods of extraction from vegetable-based sources
Infrastructure: PHS-Tomskhimpharm JSC has all the necessary infrastructure in place to ensure high-quality product manufacturing, compliant with the international standards. Specifically:
• operating workshop premises;
• warehouses;
• laboratories;
• steam unit;
• boiler house;
• garage.


General Director

Vadim Danilov

In 2004, Mr. Danilov graduated from Tomsk Polytechnic University majoring in Economics and Company Management. He began his career the same year with OJSC Industrial and Construction Bank. In 2008, he joined OJCS NOMOS-Bank, while in 2011 Vadim continued his work at Property Management Department of Drilling Service Company GRAND LLC.
In 2014, Vadim Danilov was Deputy General Director for Commercial Affairs of OJSC Pharmstandard-Tomskkhimpharm.
On February 13, 2018 he was elected General Director of OJSC Pharmstandard-Tomskkhimpharm.

History and Milestones

In 1913, the first pharmaceutical warehouse was opened in Tomsk. 6 years later at its premises the soap, galenic and chemical manufacturing was launched. In 1936, the pharmaceutical warehouse was converted into a chemical and pharmaceutical plant that manufactured tinctures, extracts, drops, ointments, adhesive bandages and tablets.
During the USSR era, the Tomsk plant turned into one of the largest state enterprises and played the key role in development of the national pharmaceutical industry over decades.
In 1992, the enterprise was reincorporated as a Joint-Stock Company.
In 2004, the Tomsk plant joined Pharmstandard Group.
Over two subsequent years, it reconstructed and refurbished the QC microbiological laboratory. The laboratory was licensed to conduct activities involving use of infectious agents and works with RG3-4 microorganisms.
The critical raw material warehouse was reconstructed, the sampling area was equipped with a “clean room” module.
In 2007, Pharmstandard JSC and Solvay Pharma SAS, France (Solvay) signed an agreement for manufacturing of two Solvay Pharma products in Russia — Imudon and IRS 19. Its finished product manufacturing and packaging was decided to arrange at PHS-Tomskhimpharm JSC.
VNIIS JSC audited the quality management system:
• Obtained Certificate of Compliance with GOST R 52249-2009 “Quality Management System. Requirements”.
• Obtained Certificate of Compliance with GOST ISO 9001-2008 (ISO 9001-2008) “Quality Management System. Requirements”.
Obtained Certificate of GMP Compliance, issued by the State Training Centre for Good Manufacturing / Distribution Practice of SE UPQI (Ukraine): 048/2014/SAUMP/GMP
Mastered new product manufacturing:
• Glycine Extra, nutrition tablets;
• Clarithromycin, film-coated tablets, 500 mg.
• Levofloxacinum, film-coated tablets, 250 mg, 500 mg, 750 mg.
• Magnelis® B6 forte, film-coated tablets, 100 mg + 10 mg.
• Mycoderil, cream for external use, 1%.
Three manufacturing sites of the company obtained Resolutions on GMP Compliance of the manufacturer of pharmaceutical products for medical use, issued by the Ministry of Industry and Trade of the Russian Federation:
• at 211, Prospekt Lenina, Tomsk - No. GMP -0012-000014/15 (dd.10.03.2015);
• at 89, Rosa Luxemburg street, Tomsk - No. GMP -0012-000015/15 (dd.10.03.2015);
• at 32, Proletarskaya street, Tomsk - No. GMP -0012-000016/15 (dd.10.03.2015).
Mastered new product manufacturing:
• Zilacomb, film-coated tablets, 300 mg + 150 mg;
• Tenofovir, film-coated tablets, 300 mg.
By the inspection results conducted by VNIIS JSC, PHS-Tomskhimpharm JSC obtained Certificate of Compliance with GOST ISO 9001-2015 “Quality Management System. Requirements”.
Launch of manufacture of 6 new products including pharmaceutical products with extended release:
• Alvelon-MF film-coated tablets, 400 mg
• Gliclazide MB Pharmstandard extended release tablets, 30 mg, 60 mg
• Formetin® Long film-coated tablets, 750 mg, 850 mg, 1000 mg
• Gluconorm® Plus film-coated tablets, 2.5 mg + 500 mg, 5 mg + 500 mg
• Cyclogemal film-coated tablets, 250 mg
• Clarithromycin extended release tablets, film-coated tablets, 500 mg
Ministry of Industry and Trade of the Russian Federation issued GMP certificates to three manufacturing sites of the company validating compliance of the pharmaceutical products with the requirements of Good Manufacturing Practice No. GMP-0012-000137/17, No. GMP-0012-000143/17, and No. GMP-0012-000144/17 dated 25.01.2017.

Development Plans

2018 It is planned to remodel the manufacturing site with the purpose of bringing it into conformity with GMP regulations, to set up manufacture of new pharmaceutical products as part of the contracts entered into with CJSC BIOKAD.



Информация на сайте предназначена исключительно для медицинских работников.

Подтвердите, пожалуйста, являетесь ли Вы медицинским работником.

Если Вы не являетесь медицинским работником, пожалуйста, покиньте данный раздел сайта.


1.На сайте представлена информация о рецептурных препаратах, их свойствах, способах применения и возможных противопоказаниях исключительно специалистам здравоохранения (лицам, имеющим высшее или среднее специальное медицинское образование).

2. Если Вы являетесь специалистом здравоохранения и хотите получить информацию с данного раздела сайта, Вам необходимо подтвердить ваш статус специалиста здравоохранения.

3. В случае если Вы не являетесь специалистом здравоохранения, но в нарушение настоящих условий подписываете данное соглашение, сайт Компании не несет ответственности за возможные отрицательные последствия, возникшие в результате самостоятельного использования Вами информации с сайта, без предварительной консультации со специалистом. Вы делаете это самостоятельно и осознанно, понимая, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом здравоохранения.

4. Информация о рецептурных препаратах, представленная на данном разделе сайте, предназначена исключительно для ознакомления с препаратами и не является руководством для самостоятельной диагностики или лечения, и не служит в качестве медицинских советов или рекомендаций. Сайт не несет ответственности за возможный ущерб, нанесенный Вашему здоровью в случае самовольного лечения, проводимого на основании применения рецептурных препаратов (без предварительной консультации со специалистом). Настоящим я подтверждаю, что являюсь специалистом здравоохранения и подтверждаю своё согласие с тем, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом.